About Bioline  All Journals  Testimonials  Membership  News

Neurology India
Medknow Publications on behalf of the Neurological Society of India
ISSN: 0028-3886 EISSN: 1998-4022
Vol. 58, Num. 2, 2010, pp. 320-321

Neurology India, Vol. 58, No. 2, March-April, 2010, pp. 320-321

Letter To Editor

Blepharospasm and vitamin B12 deficiency

Department of Neurology, Faculty of Medicine, Lund University Hospital, S-221 85 Lund, Sweden

Correspondence Address: Bengt Edvardsson, Department of Neurology, Faculty of Medicine, Lund University Hospital, S-221 85 Lund, Sweden,

Date of Acceptance: 12-Oct-2009

Code Number: ni10082

PMID: 20508362

DOI: 10.4103/0028-3886.63787


Blepharospasm is a form of focal dystonia characterized by involuntary contractions of the orbicularis oculi muscles resulting in bilateral closure of the eyes and is of two types: primary (unknown cause) and secondary (a known cause). The primary form has a gradual onset and affects mainly women in the middle age, whereas the secondary forms are associated with lesions in the basal ganglia, brainstem and thalamus. The pathophysiology is unknown. [1]

Vitamin B12 deficiency can result in various neurological syndromes: neuropathy, myelopathy, dementia, cerebellar ataxia, optic atrophy and mood disturbances. [2] Movement disorders are not usually the features of B12 deficiency in the adults [3] Whereas infants,with B12 deficiency can present with chorea, tremor, twitches, myoclonus and other abnormal movements. [4] Blepharospasm as a manifestation of B12 deficiency in adults has not been reported. We describe a patient with severe blepharospasm in whom investigations revealed low vitamin B12 levels, elevated homocysteine levels as well as other laboratory features supporting B12 deficiency.

A 51-year-old male presented with three months history of difficulty to keep eyes open. There was no history of any drug exposure. His medical history was otherwise normal. The symptoms progressed in severity but with no functional blindness. Physical examination was normal, including blood pressure. Neurological examination revealed bilateral blepharospasm grade 3 (severity, frequency) on the 0-4 Jankovic Rating Scale. He had in addition length dependent loss of vibration in both the lower and upper limbs. Computer tomography (CT) of the brain and electroencephalogram were essentially normal. A cerebrospinal fluid analysis, including neurofilament and tau protein was normal. Laboratory evaluations revealed: macrocytic anemia; MCV of 125 fL (normal range, 80-100); hemoglobin of 88 g/L (normal range, 115-150); and plasma level vitamin B12 value of 16 pmol/L (normal range, 150-650). Plasma homocysteine was 43 μmol/L (normal range < 15 μmol/L) and serum folate was 24 nmol/L (normal range 7-40 nmol/L). Serum methylmalonate and holotranscobalamine were not measured. The bone marrow was hypercellular, which is consistent with B12 deficiency. Tests for malabsorption were normal. Anti-intrinsic factor antibody serology was positive and antral biopsy was not done. Nerve conduction studies were normal. Other investigations for other causes of movement disorders were essential normal or within normal range.

A clinical diagnosis of blepharospasm secondary to B12 deficiency was made and he was initiated on intramuscular cyanocobalamin 1 mg daily for 10 days and then weekly, no other medications were prescribed. Following the treatment tests at eight weeks revealed: B12> 1500 pmoll/L, homocysteine 9.7, MCV 90 fL, hemoglobin 128 g/L and folate 21 nmol/L. At three months follow-up the blepharospasm had improved significanlty (grade 1). At 9 moth follow-up he was totally free of blepharospasm. The vibration sense in the hands and feet had also improved. He is on life-time maintenance dose of vitamin B12 therapy and he felt well at further follow-up after 3 years.

Extrapyramidal involvement due to vitamin B12 deficiency in adults is rare. In adults with vitamin B12 deficiency, focal dystonia, chorea, parkinsonism, myoclonus and even ataxia have been documented mostly as single case reports. [5],[6],[7],[8] There are no previous reports of blepharospasm in adults associated with vitamin B12 deficiency. The mechanism of extrapyramidal involvement in vitamin B12 deficiency is poorly understood. The following facts may contribute to our understanding. Vitamin B12 deficiency is the most common cause of hyperhomocysteinemia and homocysteine is required for the methylation of methionine. Homocystein has N-methyl-D-aspartate agonist action and homocystein by its action on the thalamocortical pathway may cause excitatory activity in the basal ganglia thus resulting in dystonia and chorea. [9] In addition, the excess methyl levels in B12 deficiency increase the levels of methyltetra hydrofolate, which has kainic acid agonistic action. In experimental animals, kainate produces damage similar to that seen in Huntington′s disease. [10] Also, methylmalonic acidemia, an inborn error of metabolism, usually presents with acute extrapyramidal syndrome in infants, and some of these children respond to vitamin B12 therapy. [11] Mόller et al. found elevated plasma levels of homocysteine in patients with dystonia. [12] The authors suggest that high level of homocysteine may be a contributing factor for the onset and severity of dystonia and they also recommend routine testing of plasma homocysteine and treating these patients for hyperhomocysteinemia.

It remains unclear whether cobalamin deficiency and blepharospasm in this single case is just coincidental or causally related. Both cobalamin deficiency and blepharospasm are fairly common in older patients. However, the reversibility of the syndrome with only cyanocobalamin supplementation is striking suggesting a possible causal relation between the two. In conclusion, blepharospasm can be a rare manifestation of vitamin B12 deficiency, which is reversible with therapy. Vitamin B12 levels and homocysteine levels should be tested in patients with blepharospasm in whom there is no obvious cause for blepharospasm.


1.Hallett M. Blepharospasm: Recent advances. Neurology 2002;59:1306-12.   Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 1991;70:229-45.   Back to cited text no. 2  [PUBMED]  
3.Grattan-Smith PJ, Wilcken B, Procopis PG, Wise GA. The neurological syndrome of infantile cobalamin deficiency: Developmental regression and involuntary movements. Mov Disord 1997;12:39-46.   Back to cited text no. 3  [PUBMED]  
4.Jadhav M, Webb JKG, Vaishnava S, Baker SJ. Vitamin B12 deficiency in Indian infants. A clinical syndrome. Lancet 1962;2:903-7.   Back to cited text no. 4    
5.Ahn TB, Cho JW, Jeon BS. Unusual neurological presentations of vitamin B12 deficiency. Eur J Neurol 2004;11:339-41.   Back to cited text no. 5  [PUBMED]  [FULLTEXT]
6.Kumar S. Vitamin B12 deficiency presenting with an acute reversible extrapyramidal syndrome. Neurol India 2004;52:507-9.  Back to cited text no. 6  [PUBMED]  Medknow Journal
7.Pacchetti C, Cristina S, Nappi G. Reversible chorea and focal dystonia in Vitamin B12 deficiency. N Engl J Med 2002;347:295.  Back to cited text no. 7  [PUBMED]  
8.Celik M, Barkut IK, Oncel C, Forta H. Involuntary movements associated with vitamin B12 deficiency. Parkinsonism. Relat Disord 2003;10:55-7.  Back to cited text no. 8    
9.Vitek JL, Chockkan V, Zhang JY, Kaneoke Y, Evatt M, DeLong, et al. Neuronal activity in basal ganglia with generalized dystonia and hemiballismus. Ann Neurol 1999;46:22-35.   Back to cited text no. 9    
10.Ruck A, Kramer S, Metz J, Brennan MJ. Methyltetra hydrofolate is a potent and selective agonist for kainic acid receptors. Nature 1980;287:852-3.   Back to cited text no. 10  [PUBMED]  
11.Larnaout A, Mongalgi MA, Kaabachi N, Khiari D, Debbabi A, Mebazza A, et al. Methylmalonic acidaemia with bilateral globus pallidus involvement: A neuropathological study. J Inherit Metab Dis 1998;21:639-44.   Back to cited text no. 11  [PUBMED]  [FULLTEXT]
12.Mόller T, Woitalla D, Hunsdiek A, Kuhn W. Elevated plasma levels of homocysteine in dystonia. Acta Neurol Scand 2000;101:388-90.  Back to cited text no. 12    

Copyright 2010 - Neurology India

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil